Clinical Immunoassay Analyzer Market in the US 2016-2020

Table of contents

PART 01: Executive summary

• Highlights

PART 02: Scope of the report

• Market overview
• Top-vendor offerings

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Market landscape

• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Immunoassay clinical analyzers

• Immunoassay analyzers

PART 07: Market segmentation  by application

• Immunoassay analyzer market in oncology and endocrinology in the US
• Hepatitis and retrovirus testing in US
• Infectious disease testing market in the US
• GI stool testing market in the US

PART 08: Market segmentation by product

• Instruments
• Services and spare parts

PART 09: Market drivers

• Attractive venture capital for SMEs
• Rising demand for next-generation immunodiagnostics
• Focus on partnerships and acquisitions for product development
• Focus on disease management

PART 10: Impact of drivers

PART 11: Market challenges

• Limited detection capability and complexity
• High cost of upgrading
• Reimbursement limitations

PART 12: Impact of drivers and challenges

PART 13: Market trends

• Paper-based electrochemical immunoassay devices
• Requirement of LFI by the US Army
• Government programs for biomarker-based cancer detection

PART 14: Vendor landscape

• Competitive scenario
• Abbott Diagnostics
• Beckman Coulter
• bioMérieux
• Roche Diagnostics
• Siemens Healthcare Diagnostics
• Other prominent vendors

PART 15: Key vendor analysis

• Abbott Diagnostics
• Beckman Coulter
• bioMérieux
• Roche Diagnostics
• Siemens Healthcare

PART 16: Appendix

• List of abbreviations

PART 17: Explore Technavio